gvs 111 has been researched along with Hyperglycemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anisina, EA; Durnev, AD; Gudasheva, TA; Ostrovskaya, RU; Yagubova, SS; Zhanataev, AK | 1 |
| Mamchur, VI; Pavlov, SV; Zhiliuk, VI | 1 |
2 other study(ies) available for gvs 111 and Hyperglycemia
| Article | Year |
|---|---|
Neuroprotective Dipeptide Noopept Prevents DNA Damage in Mice with Modeled Prediabetes.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Dipeptides; DNA Damage; Hyperglycemia; Insulin-Secreting Cells; Kidney; Liver; Male; Malondialdehyde; Mice; Mice, Inbred BALB C; Neuroprotective Agents; Prediabetic State; Streptozocin | 2019 |
[Role of functional state of neuronal mitochondria of cerebral cortex in mechanisms of nootropic activity of neuroprotectors in rats with alloxan hyperglycemia].
Topics: Alloxan; Amnesia; Animals; Avoidance Learning; Cerebral Cortex; Cognition; Cytidine Diphosphate Choline; Diabetes Mellitus, Experimental; Dipeptides; Hyperglycemia; Male; Membrane Potential, Mitochondrial; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Neurons; Nootropic Agents; Pentoxifylline; Piracetam; Rats; Rats, Wistar | 2015 |